Jump to:

Philip Morris

Tobacco Industry Efforts Subverting the International Agency for Research on Cancer's Secondhand Smoke Study

Date: Nov 1999
Length: 20 pages
2505646369-2505646388
Jump To Images
spider_pm 2505646369_6388

Fields

Type
REPT, REPORT, OTHER
BIBL, BIBLIOGRAPHY
CHAR, CHART, GRAPH, TABLE, MAPS
Area
SANDERS,EB (TED)/STORED FILES
Characteristic
CONF, CONFIDENTIAL
DRFT, DRAFT
OVER, OVER SIZE DOCUMENT
Named Organization
Adelf
Advisory Comm on Health Promotion
Apco
Asian Regional Tobacco Industry Science
Assn of French Speaking Epidemiologists
Assn of South East Asian Nations
Bat, British American Tobacco
Bm, Burson-Marstellar
Bw, Brown & Williamson
Cec
Cec Consultative Comm on Cancer
Cec Dept
Cec European Comm of Cancer Experts
Cec Health + Safety Advisory Comm
Cec Public Health Advisory Comm
Chemical Mfg Assn
Chinese Epidemiological Assn
Chinese Journal of Epidemiology
Ciar Conference
Ciar Workshop on Experimental Generation
Ciar, Center for Indoor Air Research
Commission of the European Union
Confederation of European Community Ciga
Consultancy Group
Consumer Policy Service
Corning Hazleton
Covance
Covington Burling
Danish Society of Epidemiology
Dept of Industry + Ecocycles
Dow Chemical France
Economist
Ecosoc Health Comm
Environmental Agencys Health + Safety
Ep Dept
Ep Environment Comm
Epa, Environmental Protection Agency
Esef
Eu, European Union
European Against Cancer
European Cancer Prevention Org
European Coalition
European Commission
European Conference
European Council
European Epidemiological Assn
European Epidemiology Group
European Health + Safety Agency
European Inst of Oncology
European Medical Assn of Smoking + Healt
European Org for Research + Treatment of
European Parliament
European Police Office
European Prospective Investigation of Ca
European Public Health Alliance
European Public Health Assn
European Science Environment Forum
European Sound Science Coalition
Europol
Expert Panel
FDA, Food and Drug Administration
Federal Focus
French Natl Anti Tobacco Comm
Gep Conference
Gep Seminar
Gep Seminar of Epidemiologists
Gep Workshop
Gesellschaft Zur Foerderung Der Biomediz
Grazet
Guangzhou Inst for Chemical Carcinogens
Guangzhou Medical College
Guardian
Harvard
Hazleton, Hazleton Labs
Horeca
Iarc Communications Strategy Group
Iarc Task Force
Iea European Council
Iea European Epidemiology Group
Iea European Group
Iemc
Inbifo, Institut Fur Biologische Forschung
Intl Agency for Research on Cancer
Intl Epidemiological Assn
Intl Union Against Cancer
Intl Union Against Tuberculosis + Lung D
Intl Union for Health Promotion + Educat
Intl Workshop on Risk Assessment + Good
London Times
NCI, Natl Cancer Inst
Ny Medical College
Org of French Speaking Epidemiologists
Organizing Comm
OSHA, Occupational Safety & Health Administration
Philip Morris
PM Iarc Task Force
PM Sound Science Coalitions
PM Task Force
Pmai, Philip Morris Asia Inc.
Pmcs, Philip Morris Corporate Services
Pmusa, Philip Morris Usa
Science + Technology Office of Assessmen
Science Forum An Intl Journal of Science
Shb, Shook,Hardy & Bacon
Sound Science Coalition
Sound Science Coalition Executive Comm
Standing Comm of European Doctors
Sunday Telegraph
Swedish Epa
Tassc, the Advancement of Sound Science Coalition
TI, Tobacco Inst
Times
Uk Advertising Standards Authority
Uk Scoth
Wall Street Journal Europe
Wd+Ho
Weinberg Group
Who, World Health Org
Wills
World Conference on Smoking + Health
Named Person
Albinus, S.
Andrade, T.
Ashby, J.
Auchter, T.G.
Bates, R.
Borelli, T.
Brook, R.
Bushong, D.
Carchman, R.
Carlo, G.
Cohen, S.M.
Doll, R.
Ellis, C.
Evans, J.S.
Frommer, R.
Glynn, P.
Graham, J.D.
Greenberg, D.
Harris
Hawkes, N.
Holland, W.
Hunter, W.
Kelly, W.J., J.R.
Koo, L.C.
Landeck, S.
Macdonald, V.
Matanoski, G.
Matthews, R.
Nolan, C.
North, D.W.
Olsen, J.
Paustenbach, D.J.
Pershagen, G.
Peto, J.
Phillips, K.
Ploger, W.D.
Proctor, C.
Ritter, M.
Rupp, J.
Rylander, R.
Sanders, T.
Saracci, R.
Schlesselman, J.J.
Slater, D.
Stackerud, M.
Starr, T.B.
Sullivan, J.
Swenberg, J.A.
Teta, M.J.
Wald, N.
Walk, R.
Weinberg, M.
Wichmann, E.
Williams, G.M.
Winokur
Wu, J.
Wynder, E.L.
Xxtom
Zzdg III
Zzdg, V.
Zzdg, X.I.
Zzdg Xii
Document File
2505646125/2505646536/I 980000 + Articles
Litigation
Feda/Produced
Master ID
2505646310/6418

Related Documents:
Site
E10
Date Loaded
11 Sep 2002
UCSF Legacy ID
bpy15c00

Document Images

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size:

Page 1: bpy15c00
PM utilized the media successfully with journalists communicating the industry's perspective. The industry lacked credibility as an objective source of information. This acknowledgment is reflected in PM's contemplation of creating a scientific journal that disregards conflict of interest disclosures, and the severe reaction against PM's advertising campaign against secondhand smoke research. Philip Morris sought to market the personal exposure and confounder studies to influential regulatory bodies and the media, even bypassing the study's author and the industry's CIAR, the study's nominal funding agency, when the study was not marketed to PM's satisfaction. Through receptive newspapers like the Sunday Telegraph, the industry could communicate directly the industry's interpretation of scientific research statistics and results. .} The communication programs allowed the industry the means of exercising control over how the IARC study would be perceived upon its publication. The "sound science" coalitions and media coverage created the appearance of an independent consensus, composed of scientists, policymakers, and media, about secondhand smoke independent of the industry_ Maintaining a low profile with the implementation of the programs helped promote credibility for these initiatives. The industry tightly coordinated and implemented these plans years before the publication of the IARC study. CONFIDENTIAL DRAFT - Do Not Distribute 67
Page 2: bpy15c00
But reputable scientists say that weak associations arent necessarily meaningful. So there's no big campaign to persuade you to give up your daily biscuit. Nor is there any sound justification for a campaign against second-hand tobacco smoke z31 A table in the advertisement listed 10 different studies with the relative risk ratio of getting a disease (e.g., lung cancer) from performing various activities (e.g., frequently cooking with rapeseed oil). This industry advertising campaign, which misrepresented the studies by y inappropriately comparing statistical results, was a bold public move by the industry. The openly industry-sponsored ads drew a rapid and severe response. The campaign was publicly criticized by the European Union social affairs commissioner,Z3Z and formed the basis for a successful legal action by a French biscuit manufacturer to halt publication of the advertisement and a separate lawsuit by the French National Anti-Tobacco Committee 233 In October 1996, the UK Advertising Standards Authority upheld a complaint that the studies were misrepresented and asked the advertisers to withdraw the advertisements.23 The heightened polarity created when the industry produces a public campaign under its own name is also the result of the lack of industry credibility. The most successful use of the media seemed to be briefing journalists about the industry's perspective. Having articles written was a tactic used for promoting the IEMC-funded Hazleton studies, and then repeated for BAT's promotion of the IARC study. In fact, the same newspaper and journalists were utilized, the Sunday Telegraph and writers Victoria Macdonald and Robert Matthews (Matthews is an ESEF member). PM looked for media coverage and means to market the confounder and exposure studies for their IARC plan, consistent with the International Consultancy Program philosophy of producing research and controversy for public affairs persons to market. Joanna Sullivan of PMCS Brussels commented to David Greenberg: You solicited my thoughts on how we can effectively progress certain of the IARC plan elements. Confounders and Exposure studies Obiectives: 1.-Ensure studies progress in such a way to provide maximum CA [PM Courtesy and Accommodation oroeraml benefit. ' -> monthly updates on progress and key findings for potential CA/scientist use and if necessary to adapt study protocol (for maximum scientific impact) -> thorough analysis of site selection to maximise use of results with national/EU target groups -> agreement from study investigator/university to publicise ongoing developments through scientific conference and media opportunities -> assess feasibility of obtaining Europe Against Cancer budget for confounders studies or other endorsement by DG V [European Union's Directorate General for Employment, Industrial Relations and Social Affairsl. 2. Marketine the confounder study results- elements could include: * pre-publication exclusive by study investigator * investigator/university to seek study endorsement by independent cancer body (EPIC?)(European Prospective Investigation of Cancer] * investigator/university to send published study direct to target groups (Annex I) * promote study results via contacts of investigator . CONFIDENT(AL DRAFT - Do Not Distribute 61 N ~ O CA Q> A 0) w N 0
Page 3: bpy15c00
; and whose quotes in the news release are used verbatim in the Sunday Telegraph article) * "The Complete Body of Statistical Evidence on Environmental Smoke" listed the statistical significance of secondhand smoke studies and stated "Relative risks are not statistically significant if the 95% confidence interval includes 1.0. When this is the case, the study has failed to reject the "null hypothesis." In the case of environmental tobacco smoke and lung cancer, it means that the study has not identified that ETS is associated with lung cancer." * "What is the International Agency for Research on Cancer" * "New opinion research on the public's views of irritating behavior" describing a BAT-sponsored survey revealing smoking in pubs and restaurants ranked lower than dog fouling in public places and bad language.104 BAT's elaborate press packet and international promotion misrepresenting the study was the primary source generating the conflicting news stories around the globe about the IARC study. The study which the industry had feared for years would lead to increased consumption restrictions now was transformed into a tool with which the industry could cast doubt upon major secondhand smoke scientific reports, like the U.K. SCOTH report. Sunmary The industry's communications strategy for the IARC study served as an adjunct to the scientific strategy. With its efforts to reach out to the IARC investigators and scientific research program, the industry could only influence IARC and the scientific community to an unknown certain extent. Just as the target goal was to ensure IARC's study would not stimulate more smoke-free legislation or rea lations, the industry broadened their communication efforts to create an environment in which policymakers would not be compelled to take action. The creation of "sound science" coalitions was PM's means of generating a critical mass of reputable voices advocating how science should be used in policymaking. TASSC in the U.S. was most likely replicated as ESEF in Europe. Although these third-party coalitions publicly appeared to be independent, public relation firms developed and managed the coalitions with the purpose of helping PM in its "legislative battles-" As the public relation firms' research demonstrated that corporate sponsorship, especially by PM, proved controversial to European scientists, PM's role in these coalitions may have been downplayed, as with TASSC, or not revealed. Although TASSC is defunct and seems to have been transformed into its former executive director's "junk science" web page, ESEF has continued to serve as a critical voice about the IARC study and secondhand smoke scientific research. The industry did not leave much to chance in managing the announcement of IARC's results. The organization of "crisis" teams across the industry ensured a well-coordinated response in case the study's results were announced unexpectedly. Such precautions were undertaken for an international basis as well. CONF[DENTIAL DRAFT - Do Not Distribute 66
Page 4: bpy15c00
CHAPTER 7: GOVERNMENT RELATIONS STRATEGY AND THE GOOD EPIDEMIOLOGY PROGRAM Introduction PM's ultimate goal for the industry's IARC study plans was to impact policymakers The policymakers would be the ones deciding how to use the IARC study for any secondhand smoke -=legislation or regulation. While theindustry has had a long history of lobbying policymakers directly, such as through the industry's Tobacco Institute lobbying organization, the industry's government relations strategy expanded the typical lobbying activities into a sophisticated communication program directly targeting policymakers. The govemment relations program was designed to influence the policymakers' evaluation processes about the risks of secondhand smoke. In keeping with its traditional lobbying activities, PM tracked public sentiment about smoking restrictions, and developed comprehensive "briefing book" materials about secondhand smoke for its own representatives and policymakers. A 1989 PM survey of 10 European countries demonstrated that "both smokers and non-smokers in Europe desire more rules in the future against smokingin public places," and that Europeans are less opposed to government involvement with smoking than Americans (Figure 2).239 Citizens of Europe actually wanted more smoking restrictions than their U.S. counterparts, even though progress has been more rapid in the U.S. To communicate indirectly with policymakers, PM developed the Good Epidemiology Practice (GEP) program. The GEP program sought to establish procedural standards for epidemiology, and subsequent seminars on GEP and good risk assessment practice were conducted throughout the world. As with the scientific and communication strategies, the government relations strategy sought to establish credibility by maintaining a low profile and incorporating the participation of third-parties. Through the GEP program, policymakers could learn from "experts," pre-screened for their participation by the industry, about how to analyze scientific risks in creating policy. Traditional Lobbying Activities With the IARC study, PM concluded "[a] European initiative to regulate exposure to ETS, be it at the Union level, national level, or both, appears not only inevitable, but also imminent."24O In September 1993, PM planned to develop a lobbying plan before and after the IARC study's release. PM sought "key national government influence points" in the IARC donor countries to "generate pressure for reorientation/reprioritization of IARC priorities/budget allocations," and planned to lobby regulatory bodies and secure preemptive legislation against smoking restrictions.90 Re-directing IARC's priorities and budget proved difficult, as described in the scientific strategy section. Targeting regulators and legislators thus comprised the heart of the industry's resulting government relations strategy. In 1994, PM developed a "ETS & IARC Briefing Book" in preparation for the IARC study. The structure of the book sections would be "written in a narrative style which can be CONFIDENTIAL DRAFT - Do Not Distribute 68
Page 5: bpy15c00
0 * generate letters to editors (scientific/general media) promoting study and highlighting EPA/other weak ETS methodology inc. IARC . * encourage libertarian policy groups to promote study and criticise the weakness of epidemiology, especially on ETS * independent scientists to push feature articles promoting confounders arguments * promote perspective argument: confounders, especially poor diet (dairy fat) and other relative risks vs. ETS, no significant risk- possibly through VNR featuring study investigator, and third party advocates of confounders arguments. 3. Marketing the exposure study results * study investigator to publicise to scientific peers via scientific journals, conference opportunities and direct to government (EU/national) scientific advisory bodies * CA use not reconunended.... Anne Targets EU: DGV [European Union's Directorate General for Employment, Industrial Relations and Social Affairs] DG XII (European Union's Directorate General on Science, Research, and Development] STOA [European Union's Science and Technology Office of Assessment] Public Health Research Deparunents (CEC/EP) EP Environment Committee Members/Secretariat _ CEC H-ealth and Safety Advisory Committee ECOSOC Health Committee/Secretariat CEC Public Health Advisory Committee CEC European Committee of Cancer Experts CEC Consultative Cornmittee on Cancer Consumer Policy Service (?) European Health and Safety Agency (?) Advisory Committee on Health Promotion (not yet established) EU Influencers - European Prospective Investigation of Cancer (EPIC) (nutrition bias) European Cancer Prevention Organisation European Public Health Alliance European Public Health Association (NGOs) . European Institute of Oncology Standing Committee of European Doctors . European Medical Association of Smoking and Health European Organisation for Research and Treaunent of Cancer (has a databse of 60,000 cancer patients "Euro-Code" which could be used for confounders study?) Intern ati on al In fluen cers IARC staff and country collaborators International Union for Health Promotion and Education International Union against Cancer International Union against Tuberculosis and Lung diseases WHO Regional Adviser for Cancer Member States Health Ministers, Ministrics, Government Committees ~-- HealthlScientific Advisory bodies National Cancer Institutes W *CEC = European Commission'3s O Cyr p) _ 4~h CONFIDENTIAL DRAFI' - Do Not Distribute 62 C" w ~ ~
Page 6: bpy15c00
PM's objective was to place articles that seemed to independently support the industry's position. PM took this objective a step further by contemplating the development of an independent journal. In April 1995, the head of PM's IARC Task Force proposed PM produce "Science Forum: An International Journal of Science and Critique." The precedent for a third-party forum, which the industry could criticize scientific research, had already been established with PM's "sound science" coalitions. The production of a scientific journal could complement the coalitions' objectives to promote appropriate use of science for policymaking: PURPOSE To provide a forum where the objective validity of statements claimed to be scientific - and therefore their technological or policy usefulness is evaluated according to the objective criteria of the scientific method. EDITORIAL POLICY Communications in all fields of science are invited, as original experimental reports, reviews, critiques, or seminal speculations. Communications are also invited in the philosophy and methods of science and the interactions of science with public interest policies. Submissions will be considered only if data presentations, evaluations, and associated critiques adhere to scientific principles of validation, according Co standard criteria of the scientific method.._. The Journal stands by the principle that what counts is-the message and not the messenger. Accordingly, the Journal does not consider submissions that include ad hominem arguments, is not concerned with personal or institutional conJlicts of interest of authors, but only with possible conflicts of their statements in relation to the above principles of the scientific method. Anonymous submissions are considered according to the same principles and provisions.230 [emphasis added] PM sought a seemingly independent journal in which it could credibly critique scientific studies and policymaking. Of note is the proposal's recommendation that the journal not be concerned with personal or institutional conflicts of interest of the authors, which would bypass a standard protocol for journals and allow the industry greater rein to promote its messages. Among other things, such a joutnal would provide another avenue for critiquing the IARC study. Discussion of these plans was scheduled on an agenda that included other IARC plans, such as a review of the IARC monograph participant selection process and a Covington and Burling's draft of a Good Epidemiology Practice Resolution for the European Union (described below in this chapter). It is not known if such a journal evolved or exists. Communication efforts using PM's name openly resulted in harsh criticisms. In 1996, PM ran a°Secondhand Tobacco Smoke in Perspective" advertising campaign across European newspapers, claiming that studies demonstrated the risks of passive smoking were trivial compared to other everyday activities_ The "evidence" that secondhand smoke did not present a meaningful health risk read in one advertisement: The United States Environmental Protection Agency recently conducted a major review of studies on the risks of second-hand tobacco smoke to non-smokers. These studies typically involve non- smokers living with smokers over a long period, such as 20 years. And this review put the risk of lung cancer from second-hand tobacco smoke,at a level well below the risk reported by other studies for many everyday items and activities. And below, in fact, the risk to health that one other study reported for eating one biscuit a day. As the table below shows. many everyday activities have been statistically associated at one tiine or another with apparent risks to health. . CONFIDENTIAL DRAFT - Do Not Distribute 60
Page 7: bpy15c00
dismiss [the study] by arguing that our research receives support from...the tobacco industry. Our findings are completely independent of any influence from the industry."227 However, not only did the Hazleton study have extensive industry involvement, but the article was probably a result of PM's public relations effort. Generating media coverage of the industry's perspective was repeated for BAT's interpretation of the IARC results, obtained from the abstract in IARC's Biennial Report_ The ~ March 1998 Sunday Telegraph story and subsequent media coverage were acknowledged by the first head of PM's IARC Task Force, Winokur, as the "publicity generated by BAT": BAT decided to publicize the information in the Biennial Report and on March 8 issued a press release highlighting what it believed were the limits of IARC's research. BAT concluded "the risk of lung cancer from environmental tobacco smoke to be either non-existent or too small to be measured at a meaningful level." The timing of BAT's initiative may have been influenced by the U.K. SCOTH report which was scheduled jor and was released March 11. SCOTH concluded that "long term exposure to environmental tobacco smoke is a cause of lung cancer" and recommended restrictions on smoking in public places, including workplace bans. On March 8 The Sunday Tele¢ranh broke the story accompanied by an editorial. On March 9 Tie Guardian and The Times also covered the story as did other U.K. newspapers and radio talk shows. The story ran in other EU markets. Also on March 9 BAT issued press releases via Brown & Williamson and W.D. & H.O. Wills. There were only small mentions in U.S. media but the story appeared in Ausrralia. On March 11 BAT held a press conference in Brazil which generated stories. BAThas indicated it will continue to promote the story in other markets.... During the week there were two significant stories. On March f I the Wall Street Journal Europe published [European Science Environment Forum's] "Smoking Out Bad Science" and the March 14 The Economist published "Smokescreens" criticizing the W.H.O. and concluding "Although passive smoking is unpleasant and irritating for non-smokers, that alone cannot justiJy banning it in public places. " Additional stories appeared in the U.K. over the March 14-15 weekend.''s'[emphasis addedl The document demonstrates BAT's primary role in the March media blitz, and unfolding of the international plan implemented by the industry. BAT even sent the Sunday Telegraph articles to a Bangladesh newspaper that refused to publish cigarette advertisements238 The Sunday Telegraph continued to be the medium for the industry's messages to the public about secondhand smoke. Of note is that Winokur regards ESEF's opinion-editorial in the Wall Street.7ournal Europe as one of the "two significant stories" of the week. The industry documents include BAT's press packet to the media about the IARC study. This press packet included: * a March 5 news release entitled "Europe's largest ever passive smoking study has failed to establish a meaningful risk of lung cancer to non-smokers" with the statement "In short, the study failed to find any statistically valid increase in lung cancer risk in non-smokers who have lived, worked or grew up with smokers." * an invitation to interview BAT spokespeople or obtain a videotape with a pre- recorded interview with.BAT's Head of Science (Chris Proctor, IEMC member CONFIDENTIAL DRAFT - Do Not Distribute 65
Page 8: bpy15c00
The entire industry was made aware of GEP's potential benefits. If an international standard for the conduct of epidemiologic studies was adopted , the results from the IARC study and anticipated monograph could potentially be criticized. PM's initially attempted to have a body of scientists adopt a PM version of GEP. The scientists would either be pre-screened by the industry or belong to a"sotmd science" coalition. The scientists' conclusions would then be communicated to policymakers. Public relations firm Burson-Marsteller first described this concept, in conjunction with other proposals to demonstrate the "misuse of science" and "ETS in perspective," in the December 1993 "Preparedness plan for the announcement of the IARC study:" A. Misuse of science survey.... B. Overview of other low level workplace risks and safety standards... * to put ETS in.perspective * to gain the support of companies by scaring them of the impact of ETS on regulation of other tow level workplace risks C. ET.S.reminnr._. ._.with the stakeholders in the ETS debate (unions, employers organisations, horeca organisations, human resources managers, etc.).... The real allies would be asked to speak at this meeting.... Objective of the meetings is _ * to have participants understand how the [sic] science is sometimes misused by activists. Philip Morris should be perceived as asupplier of credible information. * to scare the allies about the impact of hysterical legislation on smoking (and on other low level risks)200. Burson-Marsteller proposed putting the risks of secondhand smoke in perspective by holding a seminar to demonstrate the "misuse of science," and recruiting the involvement of other industries facing similar regulatory challenges. PMCS Brussels developed this concept further by proposing a European Union-endorsed seminar on GEP with selected epidemiologists: GEP Seminar Objectives: -extract an agreed set of criteria on GEP for use as a lobby tool -based on criteria developed during seminar -incite participants to lobby DG V [European Union's Directorate General for Employment, Industrial Relations and Social Affairs] to establish need for and push GEP Resolution * encourage other supportiveivulnerable industries to support seminar and promote the need for GEP criteria to be legislated - * have STOA host conference [European Union's Science and Technology Office of Assessment] * have small number of MEPs [Members of the European Parliament] endorse conference and through involvement encourage them to lobby Commission on need for GEP Resolution, possibly have EP own-initiative report on GEP * CIAR vs tobacco industry funding * ensure scientific epidemiologist participants have clear philosophy of criteria sought via careful pre- selection, pre-briefings * possibly invite DG XII? fEuropean Union's Directorate General on Science, Research, and Development] * STOA/CIAR/epidemiologists to publicise "agreed GEP criteria" to key targets and follow up with lobby efforts. ' GEP Lobby * focus seminar participants on DG V. and supplementary focus by epidemiologists on national Health Ministersz35 CONFTDENCIAL DRAFT - Do Not Distribute 72
Page 9: bpy15c00
allow Keith to participate in the brieHngs, and the lateness of the decision to go ahead, meant that no independent third party was available to provide the necessary perspective. * Covance.following itsflotation, seems determined to say as little as possible of any significance about the studies for fear of drawing attention to their involvement with the tobacco industry (though this is not KP's [author Keith Phillips) attitude). * The net result is not only a tortuous process of trying to get the studies reported at all, bur also briefing material which is neutral,and bland to the point of being devoid of media interest.... Conclusions * The abstracts should be more comprehensive and also better structured to make clearkey points which enhance understanding of air quality measurements. * A communications strategy which essentially leaves journalists to find their own way around the figures and put their own interpretation on them is counter-productive. It is essential to be much more direct and up front with what the studies could mean, offering a commentator who can give this necessary perspective on the figures- an environmental scientist or toxicologist, for example. * There is little hope of changing this situation, given the attitude of Covance/its PR advisors, and the artn's length dialogue, while certainly above reproach. makes the process management exceedingly difficult. _ * If CIAR is unable/unwilling to take a more active part in presenting the findings, the industry should brief journalisrs on the studies once they have been published in scientifec journals. There would be some loss of credibility but Covance could not dispute the information- since it would be based entirely on their research- and a third parry could be on hand to give an independent view. * In the case of Barcelona, I recommend that a follow-up briefing is given by industry scientists to Spanish journalists. "Ibis could be linked to the additional information which the Harris poll provides on perceptions of ETS. * There is an argument for waiting until all studies are published, but this will miss the opportunity to prepare the ground for lARC. There is much more to discuss, but my basic thrust is that there is no longer any point in waiting for other parties, notably Covance in this instance, to transmit a clear message about exposure- the indusrry must tackle the issue head on. "` [emphasis added] Hazleton author Philips' "emphasizing upper decile not median figures - so they are 'exaggerated"' is actually a standard environmental measurement approach, but stating the highest levels of secondhand smoke exposure would not help demonstrate that secondhand smoke exposure was minimal. As the author and organizations primarily behind the study were not marketing the study sufficiently for PM's objectives in "prepar[ing) the ground for IARC," PM wanted to take the lead in promoting an interpretation of the exposure studies. The recommendation that "the industry should brief journalists on the [exposure] studies" did seem to bear fruit. In August 1998, Robert Matthews and Victoria Macdonald of the Sunday Telegraph, who wrote the series of articles stating the IARC study did not link passive smoking and lung cancer, reported that the Hazleton studies demonstrated that "Passive smokers inhale six cigarettes a year" and that "real-life levels" of secondhand smoke probably do not cause fatal diseases.'Zl In the article, the study's author Phillips is quoted as stating "[Some scientists] try to CONFIDGNTIAL DRAE 1' - Do Not Distribute 64
Page 10: bpy15c00
PM viewed GEP as a lobbying tool, a means to communicate their view with policymakers. European Union legislators and regulatory bodies could be recruited to participate and endorse. The seminar participants would help lobby for implementation of GEP across the European Union. Continuing the lobbying concept of GEP, PM drafted versions of a GEP European Union resolution with the help of its legal resources and internal scientific departments. The provisions of the resolution were designed to specifically cover the LARC study. Sullivan of PMCS Brussels ~ asked Winokur to make preparatiot5s before their next meeting: GEP Resolution Obtain the scientific input on the draft C&B [Covington & Burling law firm] Resolution, from S&T [PM Science & Technology], and SI-IB [Shook, Hardy and Bacon law firm] as well as Tony [Andrade] and Tom Borelli to ensure that the Resolution contains the necessary language to catch the IARC study. As we discussed the crucial elements need to be identifiable to PMCS as distinct to the padding (which is important to make the Resolution politically viable). Once the changes have been agreed and incorporated, you will send around the amended version to the full IARC Task Force for final comments. Once this process is complete we will have a final text to act on here; we should aim to complete this exercise by end of June. Next meeting ...The key elements that need to be covered off at this meeting are -1 endorsement of language of Resolution -2 discussion and agreement on the feasibility, objectives, and timing of the GEP conference: you will have BM10" and APCO [Associates public relations firm] attend to present their refined plan...-3 discussion and agreement on the potential use of scientists known to C&B and SHB to promote GEP concept and Resolution wording to DGV, DGXI and their Scientific advisory cttees [slc], and same for national level. You will ask them to come prepared having identified individuals for this specific purpose, and the degree where known of their access points within EU and national government scientific/public health circles. ~a [emphasis added] PM intended for scientists selected by the industry's law firms to promote the GEP concept and resolution with European Union regulatory bodies and legislators. In the different GEP resolutions drafted,2t5.249 the "Executive Committee of the Sound Science Coalition" was listed as the author of the resolution. While The Advancement for Sound Science Coalition in the U.S., described in the scientific strategy section, had been established to help PM in its "legislative battles", a European body of scientists may have better suited PM's need to address the Europe-oriented IARC study. Unfortunately, in June 1994 Burson-Marsteller was still researching the development of a European sound science coa]ition.217 Perhaps as a substitute or a potential roster for a European coalition, in August 1994 Covington and Burling law firm created a list (Appendix Table A-4) of potential epidemiologists to invite that were screened out for anfl-tobacco views: ....[Category] B2 lists non-German candidates who appear from our research to date to be reasonably balanced on the tobacco issue and [category] B3 lists influential epidemiologists known to have strongly anti-tobacco views. There appears to be general agreement that all those on the latter list should be excluded from the seminar. We have excluded from our B2 Gst a number of the candidates suggested by Stig Albinus 20°, either because their area of expertise,appeared to be outside the boundaries of epidemiology, or because they, or their institution, or some of their close collaborators, appeared from our knowledge or research to be euremely hostile to tobacco 'S° [emphasis added] The `B3" list of anti-tobacco epidemiologists included Rodolfo Saracci, senior co-head CONFIDENTIAL DRAFT - Do Not Distribute 73

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size: